Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

Mesocortical dopamine (DA) is a key neurotransmitter in cognitive processes and is involved in schizophrenia and antipsychotic drug action. DA exerts a highly complex modulation of network activity in prefrontal cortex (PFC), possibly due to the recruitment of multiple signaling pathways and to specialized cellular localizations of DA receptors in cortical microcircuits. Using double in situ hybridization, we quantitatively assessed the expression of D(1) and D(2) receptor messenger RNAs (mRNAs) in pyramidal and gamma-aminobutyric acidergic (GABAergic) neurons of rat PFC. The proportion of pyramidal and GABA cells expressing these transcripts shows great regional variability in PFC, with little overlap (layer V). More pyramidal and GABA cells express D(1) than D(2) receptors. D(1) receptors are expressed by a greater proportion of GABA than pyramidal neurons, yet the number of D(1)-positive pyramidal cells outnumbers D(1)-positive interneurons due to the greater abundance of pyramidal neurons. Occasional PFC cells show high levels of mRNA, similar to those in striatal neurons. Finally, pyramidal and GABAergic cells expressing the same transcript were almost never found in close apposition, yet D(2)-containing pyramidal neurons were often found close to non-D(2) GABA neurons. Thus, cellular and network DA actions in PFC are region and layer specific and may depend on precise cellular interactions.

[1]  Y. Khan,et al.  Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  Anders Björklund,et al.  Organization of catecholamine neurons projecting to the frontal cortex in the rat , 1978, Brain Research.

[3]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  G. Aghajanian,et al.  Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: Antagonism by atypical antipsychotic drugs , 1994, Neuroscience.

[5]  Kuei Yuan Tseng,et al.  Dopamine modulation of prefrontal cortical interneurons changes during adolescence. , 2006, Cerebral cortex.

[6]  P. Gaspar,et al.  D1 and D2 Receptor Gene Expression in the Rat Frontal Cortex: Cellular Localization in Different Classes of Efferent Neurons , 1995, The European journal of neuroscience.

[7]  J. Seamans,et al.  The principal features and mechanisms of dopamine modulation in the prefrontal cortex , 2004, Progress in Neurobiology.

[8]  Angus C Nairn,et al.  DARPP-32: an integrator of neurotransmission. , 2004, Annual review of pharmacology and toxicology.

[9]  Clifford B Saper,et al.  An open letter to our readers on the use of antibodies , 2005, The Journal of comparative neurology.

[10]  Richard Muscat,et al.  Chronic mild stress-induced anhedonia: A realistic animal model of depression , 1992, Neuroscience & Biobehavioral Reviews.

[11]  M. Pompeiano,et al.  Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  Jeremy K Seamans,et al.  Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. , 2002, Journal of neurophysiology.

[13]  P. Celada,et al.  In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. , 2004, Cerebral cortex.

[14]  G. Mengod,et al.  GABAB receptor mRNA in the raphe nuclei: co‐expression with serotonin transporter and glutamic acid decarboxylase , 2003, Journal of neurochemistry.

[15]  P. Goldman-Rakic,et al.  Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. , 2000, Science.

[16]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  P. Greengard,et al.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 , 1984, Nature.

[18]  P. Celada,et al.  Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. , 2004, Cerebral cortex.

[19]  P. Greengard,et al.  Beyond the Dopamine Receptor: Review the DARPP-32/Protein Phosphatase-1 Cascade , 1999 .

[20]  P S Goldman-Rakic,et al.  D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Jordi Serrats,et al.  Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. , 2004, Cerebral cortex.

[22]  Kuei Yuan Tseng,et al.  D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex , 2007, Synapse.

[23]  G. Aghajanian,et al.  Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons , 1993, Brain Research.

[24]  Graham V. Williams,et al.  Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory , 2007, Nature Neuroscience.

[25]  G. Koob,et al.  Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.

[26]  B. Bunney,et al.  Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. , 1989, The Journal of pharmacology and experimental therapeutics.

[27]  P. Greengard The neurobiology of slow synaptic transmission. , 2001, Science.

[28]  A. Cooper,et al.  Predictive Reward Signal of Dopamine Neurons , 2011 .

[29]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[30]  G. Aghajanian,et al.  LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. , 1996, The Journal of pharmacology and experimental therapeutics.

[31]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[32]  P. O’Donnell,et al.  Dopamine gating of forebrain neural ensembles , 2003, The European journal of neuroscience.

[33]  T. Robbins Chemistry of the mind: Neurochemical modulation of prefrontal cortical function , 2005, The Journal of comparative neurology.

[34]  A. Grace,et al.  Regulation of firing of dopaminergic neurons and control of goal-directed behaviors , 2007, Trends in Neurosciences.

[35]  J. Glowinski,et al.  Studies on mesocortical dopamine systems. , 1978, Advances in biochemical psychopharmacology.

[36]  A. Moorman,et al.  Towards Quantitative In Situ Hybridization , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  T. Robbins,et al.  Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates , 2004, Neuroscience & Biobehavioral Reviews.

[38]  Clifford B Saper,et al.  Magic peptides, magic antibodies: Guidelines for appropriate controls for immunohistochemistry , 2003, The Journal of comparative neurology.

[39]  D. Durstewitz,et al.  The ability of the mesocortical dopamine system to operate in distinct temporal modes , 2007, Psychopharmacology.

[40]  H. Akil,et al.  Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization- receptor autoradiographic analysis , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  M. Caron,et al.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Palacios,et al.  Visualization of dopamine D1, D2 and D3 receptor mRNA's in human and rat brain , 1992, Neurochemistry International.

[43]  P. Greengard,et al.  Distribution and cellular localization of DARPP-32 mRNA in rat brain. , 1990, Brain research. Molecular brain research.

[44]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[45]  C. Beaulieu,et al.  Numerical data on neocortical neurons in adult rat, with special reference to the GABA population , 1993, Brain Research.

[46]  P. Goldman-Rakic,et al.  D1 receptors in prefrontal cells and circuits , 2000, Brain Research Reviews.

[47]  T. Robbins,et al.  Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour , 2000, Psychopharmacology.

[48]  A. Levey,et al.  D1 and D2 dopamine receptor mRNA in rat brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Iversen,et al.  Dopamine: 50 years in perspective , 2007, Trends in Neurosciences.

[50]  M. Erlander,et al.  Different distributions of GAD65 and GAD67 mRNAS suggest that the two glutamate decarboxylases play distinctive functional roles , 1993, Journal of neuroscience research.

[51]  J. Javitch,et al.  D2 Receptors Regulate Dopamine Transporter Function via an Extracellular Signal-Regulated Kinases 1 and 2-Dependent and Phosphoinositide 3 Kinase-Independent Mechanism , 2007, Molecular Pharmacology.

[52]  R. Gainetdinov,et al.  The Akt-GSK-3 signaling cascade in the actions of dopamine. , 2007, Trends in pharmacological sciences.

[53]  G. Aghajanian,et al.  Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2 -activated interneuron , 1990, Brain Research.

[54]  Bruno Giros,et al.  Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.

[55]  M. Geffard,et al.  Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level , 1987, Neuroscience.

[56]  Kuei Yuan Tseng,et al.  D 2 Dopamine Receptors Recruit a GABA Component for Their Attenuation of Excitatory Synaptic Transmission in the Adult Rat Prefrontal Cortex , 2007 .

[57]  C R Houser,et al.  Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  R. Godbout,et al.  Chapter 18 Influence of the ascending monoaminergic systems on the activity of the rat prefrontal cortex , 1991 .

[59]  H. Akil,et al.  A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques , 1991, Neuroscience.

[60]  Paul Greengard,et al.  A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions , 1983, Nature.

[61]  Larry W. Swanson,et al.  Brain Maps: Structure of the Rat Brain , 1992 .

[62]  G. Aghajanian,et al.  Alpha 1B-adrenoceptor-mediated excitation of piriform cortical interneurons. , 1996, European journal of pharmacology.

[63]  A. Rivera,et al.  Differential regional and cellular distribution of dopamine D2‐like receptors: An immunocytochemical study of subtype‐specific antibodies in rat and human brain , 1998, The Journal of comparative neurology.

[64]  G. Aghajanian,et al.  Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. , 1994, European journal of pharmacology.

[65]  A M Graybiel,et al.  The basal ganglia and adaptive motor control. , 1994, Science.

[66]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[67]  Influence of the ascending monoaminergic systems on the activity of the rat prefrontal cortex. , 1990, Progress in brain research.

[68]  F. Zhou,et al.  Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. , 1999, Journal of neurophysiology.

[69]  P. Gaspar,et al.  Subpopulations of cortical GABAergic interneurons differ by their expression of D1 and D2 dopamine receptor subtypes. , 1998, Brain research. Molecular brain research.

[70]  P. Goldman-Rakic,et al.  D1 Receptor in Interneurons of Macaque Prefrontal Cortex: Distribution and Subcellular Localization , 1998, The Journal of Neuroscience.

[71]  P. Greengard,et al.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons , 1999, Nature.

[72]  Kuei Y Tseng,et al.  Dopamine–Glutamate Interactions Controlling Prefrontal Cortical Pyramidal Cell Excitability Involve Multiple Signaling Mechanisms , 2004, The Journal of Neuroscience.

[73]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.